---
DrugClass: "[[Skeletal Muscle, Bone, and Joint Disorder Drugs]]"
SubClass: "[[Uric acid inhibitors]]"
DrugClassContra: "[[Uric acid inhibitors#Contraindications]]"
DrugClassAdverse: "[[Uric acid inhibitors#Adverse Reactions]]"
SecondaryDrugClass: 
SecondarySubClass: 
BrandName: Gloperba
Chapter: "29"
KindleLinkChap: "[Chapter 29](kindle://book?action=open&asin=B09FRF11YJ&location=15248)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
---
```smiles
CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Relief of acute attacks of gout, prevention of gout attacks
Prophylaxis: 0.5– 0.6 mg/ day orally 
Acute attack: initial dose 0.5– 1.2 mg orally or 2 mg IV, then 0.5– 1.2 mg orally q1– 2hr or 0.5 mg IV q6hr until

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action

### Side/Adverse Effects
See `= this.DrugClassAdverse`
Nausea, vomiting, diarrhea, abdominal pain, bone marrow [[Depression]]

### Interactions

`= this.ChemLink+this.file.name`

